Fluticasone, Umeclidinium, and Vilanterol Pharmacology episode artwork

EPISODE · Apr 23, 2020 · 11 MIN

Fluticasone, Umeclidinium, and Vilanterol Pharmacology

from Real Life Pharmacology - Pharmacology Education for Health Care Professionals

Fluticasone, Umeclidinium, and Vilanterol is a combination medication used in the setting of COPD. I discuss the pharmacology of this agent further in this episode. Fluticasone is the inhaled corticosteroid portion of the drug while umeclidinium is a LAMA and vilanterol is a LABA medication. Drug interactions aren’t incredibly common or strongly clinically significant, but I discuss some of them with Trelegy Ellipta. Having a once-daily dose can be advantageous to help improve patient adherence. Fluticasone, umeclidinium, and vilanterol comes as a once-daily combination. I discuss important drug interactions on the podcast, be sure to check out my latest project which is a 200+ page book on managing drug interactions in primary care. Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!

Episode metadata supplied by the publisher feed · Published Apr 23, 2020

Embed this episode

NOW PLAYING

Fluticasone, Umeclidinium, and Vilanterol Pharmacology

0:00 11:51

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Real Life Pharmacology - Pharmacology Education for Health Care Professionals?

This episode is 11 minutes long.

When was this Real Life Pharmacology - Pharmacology Education for Health Care Professionals episode published?

This episode was published on April 23, 2020.

Can I download this Real Life Pharmacology - Pharmacology Education for Health Care Professionals episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!